Position in CDXS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$161,881
-$15,107 QoQ
Shares Held
99,314
-8.5% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,189,862,767 across 287 Biotechnology names. CDXS ranks #199 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $161,881 | 99,314 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $176,988 | 108,582 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $272,838 | 111,819 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $330,756 | 135,556 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $289,602 | 107,659 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $548,931 | 115,080 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $320,868 | 104,178 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $336,641 | 108,594 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $364,973 | 104,577 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $310,285 | 101,733 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $191,029 | 101,074 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $278,734 | 99,548 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $341 | 82,462 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $366 | 78,468 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $480,000 | 79,208 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $748,925 | 71,599 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,326,299 | 64,321 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,003,656 | 64,076 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,506,782 | 64,780 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,408,726 | 62,168 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,477,938 | 64,567 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,511,465 | 69,238 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $772,926 | 65,837 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $855,136 | 75,012 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $837,267 | 75,024 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||